Catalyst Investors Get Short Shrift In $4B SXC Buyout: Suit

Law360, Wilmington (April 20, 2012, 7:39 PM EDT) -- A Catalyst Health Solutions Inc. shareholder on Friday challenged SXC Health Solutions Corp.’s proposed $4.4 billion buyout of the pharmaceutical benefits company, calling the offer “woefully inadequate” in a class action lodged in Delaware.

In a complaint filed in Delaware state court, Catalyst shareholder Hilary Coyne blasts the company’s board for signing off on the deal despite the fact that Catalyst is the fastest-growing pharmacy benefits manager in the U.S.

“Defendants' rationale for a premium price implies a fair price is unsound given the company’s strength...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.